NCT03226769 - Safety and Efficacy of TrueTear™ for the Treatment of Meibomian Gland Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 26, 2017

Primary Completion Date

December 12, 2017

Study Completion Date

December 12, 2017

Conditions

Meibomian GlandsDry Eye Syndromes

Interventions

DEVICE

TrueTear™

Intranasal application of TrueTear™ device for approximately 8 minutes at Day 0, for approximately 3 minutes at Day 7 and then daily use of TrueTear™ per participant guide.

DEVICE

Thermalon Dry Eye Compress

Application of Thermalon Dry Eye Compress at Day 0, Day 7 and daily use as per label instructions.

Trial Locations (1)

01810

Andover Eye Associates, Andover